which is better tirzepatide or retatrutide Navigating the Weight Loss Maze: vs. Retatrutide vs. Tirzepatide: Dual vs.
Description
Gastrointestinal effects represent the most likely indirect pathway
1.4% (Table 1)
Global Market Insights 2024 report GLP-1 Receptor Agonist Market states that the GLP-1 market is expected to reach a market value of $55.7 billion dollars in 2032
Individual results vary based on starting weight, diet, exercise, and adherence to the medication schedule
All authors reviewed and approved the final version of the manuscript for submission and publication
